17/11/2025
在現代醫學中,GLP-1受體促效劑等藥物已成為對抗肥胖症的有效工具。Saxenda秀身達、Wegovy善纖達、Mounjaro滿健樂、Ozempic胰妥讚是當前最受矚目的四款注射藥物。雖然它們都用於體重管理,但在藥理機制、效果和適用人群上存在重要差異。
In modern medicine, medications such as GLP-1 receptor agonists have become effective tools in the fight against obesity. Saxenda, Wegovy, Mounjaro, and Ozempic are currently four of the most prominent injectable drugs. Although they are all used for weight management, they have important differences in their pharmacological mechanisms, efficacy, and suitable user profiles.